17 results match your criteria: "Ohio State University Medical Center and James Cancer Hospital[Affiliation]"

Robotic partial nephrectomy without renal ischemia.

Urology

June 2012

Robotic Urologic Surgery, Department of Urology, The Ohio State University Medical Center and James Cancer Hospital, Columbus, OH 432010-1250, USA.

Objective: To evaluate our outcomes of robotic partial nephrectomy (RPN) without renal artery clamping (off-clamp), in order to avoid ischemic renal injury, using cold-scissor tumor excision and sutured reconstruction without ablation or other regional hypoperfusion.

Materials And Methods: Between September 2009 and October 2010, patients who underwent off-clamp RPN for ≥1 tumors were reviewed from a prospective database. All procedures were performed by a single surgeon experienced in RPN.

View Article and Find Full Text PDF

Purpose: Extended lymph node dissection for bladder cancer provides better staging, cancerous node removal and potentially survival. Minimally invasive techniques have been criticized about the ability to adequately perform extended lymph node dissection. We compared the extended lymph node dissection quality of robotic and open cystectomy by assessing node yield and positivity.

View Article and Find Full Text PDF

Clinical pathway for 3-day stay after robot-assisted cystectomy.

J Endourol

August 2011

Robotic Urologic Surgery, Department of Urology, Ohio State University Medical Center and James Cancer Hospital, Columbus, OH 43210, USA.

Background And Purpose: Typical lengths of stay after open cystectomy are 5 to 7 days, without dramatic differences reported for laparoscopic or robot-assisted cystectomy. We developed a clinical pathway for early discharge after robot-assisted cystectomy, attempting to take advantage of potentially decreased morbidity with this minimally invasive procedure and analyzed our initial outcomes.

Patients And Methods: The initial 30 consecutive patients undergoing robot-assisted cystectomy who were treated on a clinical pathway developed at our institution were reviewed.

View Article and Find Full Text PDF

Background: Chemotherapy-induced ovarian failure (CIOF) is a frequent side-effect of adjuvant chemotherapy that results in rapid bone loss. We hypothesised that zoledronic acid (ZA), a third-generation amino bisphosphonate, would prevent bone loss in premenopausal women who developed CIOF.

Methods: Women (439) were randomised to intravenous (i.

View Article and Find Full Text PDF

Study Type: Therapy (case series).

Level Of Evidence: 4. What's known on the subject? and What does the study add? The standard of care for invasive bladder cancer is open radical cystectomy with the extent of pelvic lymph node dissection impacting oncological outcomes.

View Article and Find Full Text PDF

Robot-assisted surgery is becoming more widespread, but despite adoption by most academic institutions, curricula for training residents in robotics have yet to be developed fully. Even after teaching surgeons have mastered robotic techniques, an inherent risk of avoidable injuries may persist as they seek to impart their knowledge of this relatively new surgical modality to trainees. Two cases of aortic injury during access for robot-assisted prostatectomy are described along with their successful robotic repair with root-cause analysis of the events.

View Article and Find Full Text PDF

Purpose: Tumor spillage from bladder perforation during transurethral bladder tumor resection or cystectomy risks seeding the peritoneum with transitional cell carcinoma. We determined the lowest effective mitomycin C dose to prevent tumor implantation and the potential efficacy of delayed therapy. Additionally, we investigated the effect of tumor debulking combined with intraperitoneal mitomycin C.

View Article and Find Full Text PDF

Papillary glioneuronal tumors (PGNT) are a rare, recently described form of mixed neoplasm composed of glial and neuronal components. PGNT usually occur in children and young adults, and typically demonstrate low-grade pathology, with a low proliferative index of 1-3%. Here we describe a newly diagnosed case of PGNT with a more aggressive phenotype that required irradiation and chemotherapy.

View Article and Find Full Text PDF

Objective: Laparoscopic partial nephrectomy is a technically challenging procedure with concern over limiting warm ischemia time in order to prevent irreversible injury. We investigate the feasibility of a novel approach with the potential to minimize ischemia time as well as maximize precision of tumor excision.

Materials And Methods: Seven partial nephrectomies were performed in 45-50 kg female pigs with excisions ranging in size from 2 x 2 cm to 5 x 3 cm using the following technique.

View Article and Find Full Text PDF

Neurological complications are common in recreational divers diagnosed with decompression illness (DCI). Prior reports suggest that hemoconcentration, with hematocrit values of 48 or greater, increase the risk for more severe and persistent neurological deficits in divers with DCI. Herein we describe our experience with neurological DCI and hematocrit values in a large series of consecutively treated divers.

View Article and Find Full Text PDF

Prognosis of refractory neurosarcoidosis altered by thalidomide: a case report.

J Med Case Rep

January 2008

Dardinger Neuro-Oncology Center, Division of Neuro-Oncology, and Department of Neurology, The Ohio State University Medical Center and James Cancer Hospital & Solove Research Institute, Columbus, Ohio, USA.

Introduction: Sarcoidosis is a multisystem disease characterized by noncaseating granulomas in the lungs, skin, lymph nodes, and, rarely, the nervous system. Granuloma formation in sarcoidosis is mediated by increased secretion of interferon-gamma, interleukin-2, and tumor necrosis factor-alpha. 25% of patients with neurosarcoidosis are steroid resistant and another 20-40% are resistant to any conventional immunosuppression, but the typical agents suppress the immune system in a non-specific fashion.

View Article and Find Full Text PDF

During intra-arterial (IA) chemotherapy of brain tumors, the initial vessels chosen for infusion are based on the vascular distribution of the tumor as revealed by CT or MR imaging. However, angiography may reveal details of vascular anatomy that require an alteration of the vessel infusion plan. The incidence of infusional alterations and the underlying vascular anatomy involved remains unknown in patients with brain tumors undergoing IA chemotherapy.

View Article and Find Full Text PDF

Intra-arterial chemotherapy of primary brain tumors.

Curr Treat Options Oncol

November 2005

Dardinger Neuro-Oncology Center and Division of Neuro-Oncology, Department of Neurology, The Ohio State University Medical Center and James Cancer Hospital and Solove Research Institute, 1654 Upham Drive, Columbus, OH 43210, USA.

Intra-arterial (IA) chemotherapy is a form of regional delivery to brain tumors, designed to enhance the intra-tumoral concentrations of a given drug, in comparison with the intravenous route. Drugs that are likely to benefit from IA delivery have a rapid systemic clearance and include carmustine and other nitrosoureas, cisplatin, carboplatin, etoposide, and methotrexate. Clinical studies have demonstrated activity of IA chemotherapy approaches for low- and high-grade gliomas, and for cerebral lymphomas.

View Article and Find Full Text PDF

Chemotherapy for the treatment of metastatic brain tumors.

Expert Rev Anticancer Ther

October 2002

Division of Neuro-Oncology, Department of Neurology, Ohio State University Medical Center and James Cancer Hospital and Solove Research Institute, 1654 Upham Drive, Columbus, Ohio 43210, USA.

Metastatic brain tumors are the most common complication of systemic cancer and affect 20-40% of all adult cancer patients. Whole-brain radiotherapy and surgical resection of accessible, solitary lesions have been the mainstay of treatment. Recently, chemotherapy has become a more viable treatment option for metastatic brain tumors.

View Article and Find Full Text PDF

Recurrent and progressive non-GBM gliomas are a diverse group of brain tumors that often respond poorly to adjuvant chemotherapy treatment. Regional intra-arterial (IA) administration of chemotherapy may result in increased tumor uptake of drug, with improvement in response rates and time to progression (TTP). Twenty-five patients with recurrent or progressive non-GBM gliomas were treated with IA carboplatin (200 mg/m2/d) and intravenous (IV) etoposide (100 mg/m2/d) for 2 days every 4 weeks.

View Article and Find Full Text PDF

Fallopian tube carcinoma is the least common neoplasm of the female genital tract. Although rare, neurological complications such as brain metastases can develop. It remains unclear, however, what role chemotherapy has in the treatment of these patients and what route of administration is most effective.

View Article and Find Full Text PDF